Medicine & Life Sciences

1. abiraterone 10%
2. Abiraterone Acetate 21%
3. Adenocarcinoma 10%
4. Androgen Receptors 11%
5. Androgens 9%
6. Aneuploidy 9%
7. Atlases 50%
8. Bone Neoplasms 10%
9. Carboplatin 9%
10. Castration 75%
11. Cell-Free Nucleic Acids 11%
12. Cholangiocarcinoma 9%
13. Clinical Trials 14%
14. Confidence Intervals 9%
15. Cryoglobulinemia 11%
16. DNA Repair 13%
17. Docetaxel 9%
18. Drug Therapy 18%
19. Exome 21%
20. Genes 22%
21. Genome 40%
22. Genomics 22%
23. Hormones 10%
24. Immunotherapy 11%
25. Long Noncoding RNA 11%
26. Machine Learning 10%
27. Melanoma 27%
28. Mutation 35%
29. Neoplasm Genes 17%
30. Neoplasm Metastasis 17%
31. Neoplasms 77%
32. Network Meta-Analysis 17%
33. Nivolumab 9%
34. olaparib 15%
35. pembrolizumab 14%
36. POEMS Syndrome 13%
37. Poly(ADP-ribose) Polymerase Inhibitors 26%
38. Precision Medicine 12%
39. Prednisone 13%
40. Progression-Free Survival 15%
41. Prostate-Specific Antigen 23%
42. Prostatic Neoplasms 100%
43. Radium-223 21%
44. Renal Cell Carcinoma 28%
45. rovalpituzumab tesirine 9%
46. rucaparib 41%
47. Survival 26%
48. Systematic Reviews 13%
49. Testicular Germ Cell Tumor 18%
50. Therapeutics 26%